These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 32536234)
1. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients. Rashed RA; Hassan NM; Hussein MM Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia. Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103 [TBL] [Abstract][Full Text] [Related]
3. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105 [TBL] [Abstract][Full Text] [Related]
4. Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia. Elhamamsy AR; El Sharkawy MS; Zanaty AF; Mahrous MA; Mohamed AE; Abushaaban EA Int J Mol Cell Med; 2017; 6(2):77-86. PubMed ID: 28890884 [TBL] [Abstract][Full Text] [Related]
5. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia. Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of miR-96 in patients with acute myeloid leukemia. Zhao J; Lu Q; Zhu J; Fu J; Chen YX Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958 [TBL] [Abstract][Full Text] [Related]
7. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. Lin X; Wang Z; Wang Y; Feng W Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia. Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia. Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758 [TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia. Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040 [TBL] [Abstract][Full Text] [Related]
12. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia. Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593 [TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of miR-92a in patients with gastric cancer. Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436 [TBL] [Abstract][Full Text] [Related]
15. [The value of serum microRNA-92a and microRNA-146a levels combined with pulmonary ultrasound score in predicting the severity and prognosis of acute respiratory distress syndrome]. Yu Y; Liu Z; Liao H; He Y; Li C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1231-1235. PubMed ID: 33198870 [TBL] [Abstract][Full Text] [Related]
16. Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients. Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G Biomark Med; 2015; 9(5):453-60. PubMed ID: 25620533 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia. Zhang P; Sun D; Sun X; Li H Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467 [TBL] [Abstract][Full Text] [Related]
18. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia. Yan J; Wu G; Chen J; Xiong L; Chen G; Li P Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia. Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923 [TBL] [Abstract][Full Text] [Related]
20. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia. Weng H; Lal K; Yang FF; Chen J Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]